• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

A8C1:GR

5.797 EUR 0.003 0.05%

As of 02:08:17 ET on 12/23/2014.

Snapshot for Abcam PLC (A8C1)

Open: 5.839 Day's Range: 5.797 - 5.839 Volume: 0
Previous Close: 5.800 52wk Range: 4.212 - 6.298 1-Yr Rtn: +3.81%

Stock Chart for A8C1

No chart data available.
  • A8C1:GR 5.839
  • 1D
  • 1M
  • 1Y
5.800
Interactive A8C1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A8C1

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 24.3058
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (06/2015) 0.1870
Est. PEG Ratio 1.9445
Market Cap (M EUR) 1,164.42
Shares Outstanding (M) 200.87
30 Day Average Volume 53
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.86%
Cash Dividend (GBp) 5.6200
Dividend Ex-Date 11/06/2014
5 Year Dividend Growth 29.46%
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A8C1

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for A8C1

Abcam PLC produces and distributes research-grade antibodies via an online catalog. The Company's customers include universities, research institutes, and pharmaceutical and biotechnology companies in countries around the world.

Jonathan Simon MilnerDeputy Chairman/Co-FounderAlan HirzelChief Executive Officer
Jeff IliffeCFO/SecretaryJim WarwickChief Operating Officer
More Company Profile & Key Executives for A8C1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil